Hers semaglutide refers to semaglutide prescribed through the Hers telehealth platform, one of several direct-to-consumer services that connect patients with licensed clinicians who may recommend the medication for weight management. The specific product dispensed — FDA-approved Wegovy versus compounded semaglutide — varies by program and over time. This is an informational overview, not an endorsement of any specific platform.
What Semaglutide Is
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes. It mimics a gut hormone that signals the pancreas to release insulin, slows stomach emptying, and reduces appetite through action in the brain. According to the FDA, semaglutide is sold under three brand names:
| Brand | FDA-Approved Use | Route |
|---|---|---|
| Ozempic | Type 2 diabetes | Weekly injection |
| Wegovy | Chronic weight management | Weekly injection |
| Rybelsus | Type 2 diabetes | Daily oral tablet |
In clinical trials, Wegovy produced average weight loss of about 15 percent of body weight over 68 weeks — a large effect by historical standards for a non-surgical therapy.
How Telehealth GLP-1 Programs Work
Direct-to-consumer telehealth platforms generally follow a similar flow:
- Customer completes an online health questionnaire.
- A licensed clinician reviews the information, sometimes with a video or phone visit.
- If appropriate, the clinician writes a prescription.
- The medication ships from an affiliated or contracted pharmacy.
- Ongoing support may include check-ins, side-effect management, and dose adjustments.
The depth of the clinical encounter varies substantially. Some platforms require baseline labs from your primary care doctor and perform meaningful video visits. Others rely almost entirely on self-reported questionnaires. This variation is important to understand before enrolling.
FDA-Approved vs. Compounded Semaglutide
A key question for any telehealth GLP-1 program is which product they dispense. FDA-approved semaglutide (Ozempic, Wegovy, Rybelsus) is manufactured by Novo Nordisk under strict quality controls. Compounded semaglutide is prepared by a pharmacy from bulk active pharmaceutical ingredient, typically because the FDA-approved version was in shortage or because compounded versions are cheaper.
Differences to understand:
- FDA approval status: Only the Novo Nordisk products are FDA-approved. Compounded versions are not reviewed for safety or efficacy.
- Potency variation: Compounded products can vary between pharmacies and even between batches.
- Salt forms: The FDA has warned against semaglutide salts (e.g., semaglutide sodium, semaglutide acetate) that are not found in approved products.
- Shortage status: As FDA-recognized shortages resolve, compounding permissions typically tighten.
Visit the prediabetes treatment hub for broader context on evidence-based care options.
What Good Clinical Oversight Looks Like
Whether you use a telehealth platform or an in-person clinic, comprehensive GLP-1 care typically includes:
- Baseline labs: A1C, fasting glucose, kidney function, liver enzymes, thyroid (TSH), lipid panel.
- Contraindication screening: Personal or family history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, gastroparesis, or pregnancy.
- Dose escalation: Starting at the lowest dose and titrating up every four weeks as tolerated.
- Side effect monitoring: Nausea, vomiting, diarrhea, reflux, and early signs of more serious issues like gallbladder disease or pancreatitis.
- Follow-up labs: Repeat A1C and relevant labs every three to six months.
- Coordination with primary care: Records shared with your PCP, especially if you have other chronic conditions.
Review your A1C levels as part of any metabolic treatment plan.
Questions to Ask Before Enrolling in Any Telehealth GLP-1 Program
- Will I receive FDA-approved Wegovy/Ozempic or compounded semaglutide?
- Who is the licensed prescribing clinician? What state are they licensed in?
- Are baseline labs required? Are they included in the cost?
- How are side effects reported and addressed?
- What is the total monthly cost, including medication, visits, and shipping?
- Can I keep my own primary care doctor involved? Will you share records?
- What happens if I have a complication requiring in-person care?
- What is the policy if the medication is discontinued or a shortage returns?
Red Flags in Any Telehealth GLP-1 Service
Be cautious of programs that:
- Prescribe after a 60-second questionnaire with no visit or follow-up
- Refuse to name the prescribing clinician or pharmacy
- Advertise “generic Ozempic” at implausibly low prices
- Do not require any labs at baseline or after starting
- Ship product internationally or from unnamed facilities
- Claim results dramatically exceeding published clinical trials
The Bottom Line
Hers semaglutide, and similar telehealth GLP-1 offerings, represent one pathway to accessing a highly effective class of medications. Whether any specific program is a good fit depends on what product is dispensed, how rigorous the clinical evaluation is, and how well it coordinates with the rest of your care. Prioritize services with licensed clinicians, real labs, and ongoing monitoring — and always consult your own doctor before starting any GLP-1 therapy.
This article is for educational purposes only and is not a substitute for medical advice. Treatment decisions should be made with a licensed clinician familiar with your full medical history.
